Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 18”

51 trials

Showing 20 of 51 results

Large-scale testing (Phase 3)Study completedNCT01565382
What this trial is testing

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 40
Not applicableWithdrawnNCT04100889
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more
ProgenaBiome
Not applicableStudy completedNCT01834716
What this trial is testing

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study

Who this might be right for
Alzheimer's Disease Prevention
Mayo Clinic 16
Testing effectiveness (Phase 2)Study completedNCT00566397
What this trial is testing

Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 402
Large-scale testing (Phase 3)Study completedNCT01265394
What this trial is testing

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Who this might be right for
Healthy
GE Healthcare 218
Large-scale testing (Phase 3)Study completedNCT01447719
What this trial is testing

Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 110
Large-scale testing (Phase 3)Study completedNCT01689233
What this trial is testing

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 800
Large-scale testing (Phase 3)Study completedNCT00857415
What this trial is testing

Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 226
Testing effectiveness (Phase 2)Study completedNCT00855868
What this trial is testing

Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT04840992
What this trial is testing

Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation

Who this might be right for
COVID-19
CanSino Biologics Inc. 840
Testing effectiveness (Phase 2)UnknownNCT04398147
What this trial is testing

Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada

Who this might be right for
COVID-19
CanSino Biologics Inc. 696
Early research (Phase 1)Study completedNCT01565343
What this trial is testing

18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 25
Not applicableStudy completedNCT00299676
What this trial is testing

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

Who this might be right for
Alzheimer DiseaseDementiaGalantamine
Janssen-Cilag Pty Ltd 61
Large-scale testing (Phase 3)Study completedNCT04526990
What this trial is testing

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Who this might be right for
COVID-19
CanSino Biologics Inc. 44,247
Testing effectiveness (Phase 2)WithdrawnNCT02707978
What this trial is testing

F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)

Who this might be right for
Alzheimer Disease
Tammie L. S. Benzinger, MD, PhD
Early research (Phase 1)Study completedNCT01564706
What this trial is testing

18F-AV-45 in Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 9
Post-approval studies (Phase 4)Study completedNCT02553928
What this trial is testing

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Who this might be right for
Alzheimer Dementia (AD)
H. Lundbeck A/S 62
Not applicableStudy completedNCT01565369
What this trial is testing

Evaluation of Physician Training Methods to Read Florbetapir-PET Scans

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 35
Not applicableStudy completedNCT01550549
What this trial is testing

Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases
Avid Radiopharmaceuticals 151
Large-scale testing (Phase 3)Study completedNCT00103649
What this trial is testing

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,306
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation